ARCS Weekly News Wrap – Week Ending 25 October 2025
This week’s episode covers a powerhouse mix of policy shifts, scientific breakthroughs, and leadership changes shaping Australia’s life sciences landscape.
Join Tim Boyle, CEO of ARCS Australia, as he unpacks:
Pharma: Landmark PBS listings, proactive pharmacovigilance, and new rare disease breakthroughs
Medtech: HTA review tensions, hospital funding reform, and insights from the MTAA Conference
Biotech & Investment: A wave of clinical trials, capital raises, and global research collaborations
People Movement: Leadership transitions at Gilead, Moderna, and Omico that will influence the sector’s next chapter
Partner with ARCS: How collaboration continues to drive innovation and workforce capability across the life sciences ecosystem
It’s a fast-paced, insightful wrap of the week’s most important developments — helping you stay informed, connected, and ahead of the curve.
🎥 Watch the full episode now and don’t miss your chance to be part of the only professional network that connects every corner of the Australian life sciences sector.
👉 Join ARCS today: www.arcs.com.au/join
#ARCSWeeklyWrap #LifeSciences #Pharma #Medtech #Biotech #ARCSAustralia #ARCS2025Leaders
